Product
CU-20401
Aliases
cu-20401, Subcutaneous injection of CU-20401
3 clinical trials
3 indications
Indication
Efficacy and SafetyIndication
SafetyIndication
Healthy SubjectsClinical trial
A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of CU-20401 for Injection in Moderate to Severe Contour Protuberance or Excessive Enrichment Due to Submental Fat (SMF) AccumulationStatus: Recruiting, Estimated PCD: 2024-07-08
Clinical trial
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single Subcutaneous Injection of CU-20401 in Chinese Healthy PopulationStatus: Recruiting, Estimated PCD: 2023-07-30
Clinical trial
a Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 Administered Subcutaneously in the Submental Fat (SMF) PopulationStatus: Completed, Estimated PCD: 2022-12-30